REVANCE THERAPEUTICS INC shareholders Q4 2022

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 195 filers reported holding REVANCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

REVANCE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
VOYA INVESTMENT MANAGEMENT LLC 30,522$563,4360.00%
NEW YORK STATE COMMON RETIREMENT FUND 52,608$9710.00%
Walleye Trading LLC 17,600$324,8960.00%
Walleye Trading LLC 28,083$518,4120.00%
AMERIPRISE FINANCIAL INC 234,269$4,325,0000.00%
BELLEVUE ASSET MANAGEMENT, LLC 76$1,3830.00%
Burleson & Company, LLC 320$5,9070.00%
BANK OF AMERICA CORP /DE/ 175,909$3,247,2790.00%
OSAIC HOLDINGS, INC. 3,600$65,6920.00%
HSBC HOLDINGS PLC 19,000$349,5860.00%
U.S. Capital Wealth Advisors, LLC 250$4,6150.00%
NISA INVESTMENT ADVISORS, LLC 60$10.00%
BerganKDV Wealth Management, LLC 38$7010.00%
QUADRANT CAPITAL GROUP LLC 160$2,9540.00%
IFP Advisors, Inc 75$20.00%
SJS Investment Consulting Inc. 2$370.00%
Schubert & Co 1$180.00%
Washington Trust Advisors, Inc. 197$3,6370.00%
PRICE T ROWE ASSOCIATES INC /MD/ 43,365$8010.00%
JANUS HENDERSON GROUP PLC 13,795$254,5890.00%
External links

This page lists REVANCE THERAPEUTICS INC's shareholders in Q4 2022. To view REVANCE THERAPEUTICS INC's shareholder history, click here.